Cerebral perfusion in hypertensives with carotid artery stenosis: A comparative study of lacidipine and hydrochlorothiazide

Blood Pressure

Volumn 9, Issue 1, 2000, Pages 34-39

  Semplicini, Andrea ^a   Maresca, Andrea ^b   Simonella, Cinzia ^b   Chierichetti, Franca ^b   Pauletto, Paolo ^b   Meneghetti, Giorgio ^b   Ferlin, Giorgio ^b   Pessina, Achille C ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b NONE

Author keywords

Arterial hypertension; Cerebral perfusion; Dihydropyridine calcium entry blockers; Hydrochlorothiazide; Lacidipine; SPECT

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HYDROCHLOROTHIAZIDE; LACIDIPINE;

ADULT; AGED; ARTICLE; BRAIN; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASCULAR RESISTANCE;

EID: 0034044609     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370500439407     Document Type: Article

References (32)

1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
2. Skoog I, Lernfelt B, Landahl S, et al. A 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-5.
3. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349: 151-4.
4. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998; 31: 780-6.
5. Erkinjutti T, Hachinski V. Rethinking vascular dementia. Cerebrovasc Dis 1993; 3: 3-23.
6. Leys D, Pruvo JP, Scheltens PH, et al. Leukoaraiosis: relationship with the types of focal lesions occurring in acute cerebrovascular disorders. Cerebrovasc Dis 1992; 2: 169-76.
7. Strassburger TL, Lee HC, Daly EM, et al. Interactive effects of age and hypertension on volumes of brain structures. Stroke 1997; 28: 1400-7.
8. Sabri O, Ringelstein EB, Hellwig D, et al. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke. 1999; 30: 556-6.
9. Semplicini A, Meneghetti G, Chierichetti F, et al. SPECT evaluation of cerebral perfusion in uncomplicated essential hypertension and effects of enalapril. Cerebrovasc Dis 1994; 4: 354-8.
10. Semplicini A, Simonella C, Meneghetti G, et al. Effects of fosinopril and hydrochlorothiazide on cerebral perfusion in uncomplicated essential hypertension. J Hypertens 1993; 11 (Suppl 5): S372-S373.
11. Claudiani F, Stimamiglio P, Castello C, Villavecchia G, Cabria M, Bertolazzi L. Semiquantitative evaluation of regional cerebral flow by means of SPECT with 99Tc-hexamethyl-propylene amine oxime in hypertensive patients under treatment. J Nucl Biol Med 1993; 37: 1-5.
12. World Health Organization - International Society of Hypertension Guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-83.
13. Chen JC, Salvian AJ, Taylor DC, Teal PA, Marotta TR, Hsiang YN. Predictive ability of duplex ultrasonography for internal carotid artery stenosis of 70%-99%: a comparative study. Ann Vasc Surg 1998; 12: 244-7.
14. Battistin L, Pizzolato G, Dam M, et al. Single-photon emission computed tomography study with 99mTc hexamethylpropyleneamine oxime in dementia: Effects of acute administration of L-acetylcarnitine. Eur Neurol 1989; 29: 261-5.
15. Matsui T, Hirano A, eds. An atlas of the human brain for computerized tomography. New York: Igaku-Shoin, 1978.
16. Liu K, Stamler J, Dyer A, McKeever P, McKeever J. Statistical methods to assess and minimize the role of intraindividual variability in obscuring the relationship between dietary lipids and serum cholesterol. J Chron Dis 1978; 31: 399-418.
17. Filley ChM, Franklin GM, Heaton RK, Rosenberg NL. White matter dementia: clinical disorders and implications. Neuropsychiatry Neuropsychol Behav Neurol 1989: 239-54.
18. Pantoni L, Garcia JH. Cognitive impairment and cellular/ vascular changes in the cerebral white matter. Ann NY Academy Sci 1997; 826: 92-102.
19. Perani D, Di Piero V, Lucignani G, et al. Remote effects of subcortical cerebrovascular lesions: a SPECT cerebral perfusion study. J Cereb Blood Flow Metab 1988; 8: 560-7.
20. Reiche W, Weiller C, Weigmann R, et al. Vergleich von MRT und SPECT Befunden bei Patienten mit zerebraler Mikroangiopathie. Nuklearmedizi 1991; 30: 161-9.
21. Kobari M, Meyer JS, Ichio M. Leuko-araiosis, cerebral atrophy and cerebral perfusion in normal aging. Arch Neurol 1990; 47: 161-5.
22. Yao H, Sadoshima S, Kuwabara Y, Ichiya Y, Fujishima M. Cerebral blood flow and oxygen consumption in patients with vascular dementia of the Binswanger type. Stroke 1990; 21: 694-9.
23. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. Stroke 1991; 22: 609-14.
24. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Severity of vascular dementia is related to volume of metabolic impaired tissue. Arch Neurol 1992; 49: 909-13.
25. Paulson OB, Strandgaard S. Hypertensive disease and cerebral circulation. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology diagnosis and treatment. New York: Raven Press, 1995: 445-63.
26. Godfraind T, Salomone S. Calcium antagonist and arterial function: focus on nitric oxide and endothelin. Cardiovasc Drugs Ther 1996; 10: 439-46.
27. Akopov SE. Nitric oxide (EDRF) enhances the vasorelaxing effects of dihydropiridine calcium antagonist in isolated human middle cerebral arteries. Methods Find Exp Clin Pharmacol 1996; 18: 101-4.
28. Stirling Meyer J, Rogers RL, Mortel KF. Prospective analysis of long-term control of mild hypertension on cerebral blood flow. Stroke 1985; 16: 985-90.
29. Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology 1998; 17: 2-9.
30. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
31. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347-51.
32. Fujii K, Sadoshima S, Okada Y, et al. Cerebral blood flow and metabolism in normotensive and hypertensive patients with transient neurologic deficits. Stroke 1990; 21: 283-90.